Psychopharmacology and Psychiatry Updates

213 Folgen

1. Acute Agitation and Dexmedetomidine: A Novel Treatment Approach

   Vom: 30.8.2023
2. The Prevalence and Risks of RBD

   Vom: 25.8.2023
3. ADHD Medication and Their Role in Anxiety and Depression

   Vom: 20.8.2023
4. In the Realm of Sleep: RBD Diagnosis Explained

   Vom: 15.8.2023
5. NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?

   Vom: 10.8.2023
6. Child Psychiatry: NAC and SAMe

   Vom: 5.8.2023
7. Youth Psychotropic Prescription Trends: Pandemic Influence

   Vom: 31.7.2023
8. Nature's Remedies in Youth: St. John's Wort and Valerian

   Vom: 26.7.2023
9. Exploring Serotonergic Antidepressants for PMDD

   Vom: 21.7.2023
10. Exploring Omega-3's Role in Child Psychiatry

    Vom: 16.7.2023
11. ADHD Meds for Preschoolers: Lisdexamfetamine

    Vom: 11.7.2023
12. Using Ginkgo Biloba in Children

    Vom: 6.7.2023
13. Examining COVID's Lasting Effects in Psychiatry

    Vom: 1.7.2023
14. Beyond SSRIs: Antipsychotic Augmentation in OCD

    Vom: 26.6.2023
15. Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs

    Vom: 21.6.2023
16. Exploring Outcomes and Strategies in OCD Treatment After the First Trial

    Vom: 16.6.2023
17. Diving Into the APA Annual Meeting: Highlights and Insights!

    Vom: 11.6.2023
18. Exploring the Intriguing World of Microdosing Psilocybin

    Vom: 6.6.2023
19. SSRIs for OCD: A Closer Look at First-Line Treatment

    Vom: 1.6.2023
20. Exploring Nonstimulant Treatments for ADHD

    Vom: 27.5.2023